ConSynance Therapeutics
PrivateLast Round
Grant
Apr 15, 2026
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ConSynance Therapeutics is a biopharmaceutical company that develops treatments for central nervous system diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ConSynance Therapeutics Comparables
Compare ConSynance Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Saniona AB | 78% | |
| Aardark Therapeutics | 77% | |
| Relmada Therapeutics | 74% |
ConSynance Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 15, 2026 | ||||
| Divestiture | Aug 9, 2021 |
ConSynance Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Foundation for Prader-Willi Research | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 220% MoM.
- Apr 15, 2026
Received grant from Foundation for Prader-Willi Research.
ConSynance Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ConSynance Therapeutics's valuation, stock price, and market status.
Is ConSynance Therapeutics a public or private company?
ConSynance Therapeutics is a private company.
What is the current stock price of ConSynance Therapeutics?
ConSynance Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is ConSynance Therapeutics worth (valuation)?
Valuation information for ConSynance Therapeutics is not publicly available.
Can I buy ConSynance Therapeutics stock?
ConSynance Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ConSynance Therapeutics's last funding round?
Funding round information for ConSynance Therapeutics is not publicly available.
Who are the main investors in ConSynance Therapeutics?
Investor information for ConSynance Therapeutics is not publicly disclosed.
Will ConSynance Therapeutics IPO soon?
No public IPO plans have been announced for ConSynance Therapeutics.
How can I track ConSynance Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ConSynance Therapeutics's secondary market activity and sign up for updates.